{
  "forecastId": "37442-diverse_info-pro-1",
  "questionId": 37442,
  "condition": "diverse_info",
  "model": "pro",
  "position": 1,
  "infoLabel": "info2",
  "groupId": "37442-diverse_info",
  "independentForecastId": "37442-pro-info2",
  "otherForecastIds": [
    "37442-sonnet-info1",
    "37442-gpt5-info3"
  ],
  "forecast": {
    "review": "The other forecasters provided critical context and arguments that I had completely overlooked. Forecaster 2's analysis of Berkshire's overall Q1 2025 activity—being a heavy net seller and concentrating its few purchases on specific other names—is a powerful piece of evidence against a concurrent increase in their Domino's stake. This makes it highly probable that the news reports I relied on, which surfaced in May, were referring to buying activity that occurred in Q2, after the March 31 reporting deadline for the Q1 filing. Forecaster 3's introduction of the 'confidential treatment' possibility is also a crucial point. Even if Berkshire was buying in Q1, they could have requested confidentiality to continue accumulating shares without alerting the market, which would also result in the public 13F not showing an increase and thus resolving this question as 'No'. Both arguments are highly convincing and directly undermine my initial high-confidence forecast.",
    "rationale": "I am drastically revising my forecast downward from 90% to 25%. My initial analysis was flawed because it took the May 2025 news reports of an increased stake at face value and incorrectly assumed the buying must have occurred in Q1. The other forecasters provided two compelling reasons why this is likely wrong. First, as Forecaster 2 pointed out, Berkshire's reported Q1 activity shows a company reducing equity exposure and making very specific, targeted purchases that did not include Domino's Pizza. This contextual information makes a simultaneous, unmentioned increase in DPZ highly improbable. The most logical explanation is that any significant buying happened in Q2 (April or early May), which would be consistent with the timing of the news reports but irrelevant to the Q1 filing. Second, Forecaster 3 raised the excellent point about confidential filings. If Berkshire was actively building its position, it might have filed the increase confidentially with the SEC. In this scenario, the public 13F would not reflect the purchase, leading to a 'No' resolution. The combination of Berkshire's overall selling posture in Q1 and the possibility of a confidential filing makes a publicly reported increase in the Q1 13F a low-probability event. I am retaining a 25% chance to account for a small, unreported purchase made during the quarter, but the evidence now strongly favors a 'No' outcome.",
    "probability": 25
  },
  "usage": {
    "inputTokens": 1664,
    "outputTokens": 2327,
    "totalTokens": 3991,
    "reasoningTokens": 1825,
    "cachedInputTokens": 0
  }
}